Jian-Ping Hao

发表

Identification of key genes and miRNA-mRNA regulatory networks associated with bone marrow immune microenvironment regulations in multiple myeloma by integrative bioinformatics analysis

M. Uddin, J. Qu, Jie Wang, 2022, Hematology.

Synergistic inhibitory effect of Smo inhibitor jervine and its combination with decitabine can target Hedgehog signaling pathway to inhibit myelodysplastic syndrome cell line

M. Jiang, Jie Wang, Niluopaer Tuerxun, 2021, Hematology.

Sonic hedgehog signaling pathway in Myelodysplastic Syndrome: abnormal activation and jervine intervention.

M. Jiang, Yuting Qin, Fang Zhao, 2020, Gene.

Clinical characteristics and risk factors for acute graft-versus-host disease in related HLA-haploidentical without ex vivo T cell depletion peripheral blood HSCT

M. Jiang, X. Duan, N. Pang, 2019 .

Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia

Xuan-Sheng Ding, M. Uddin, Yun Wu, 2021, Aging.

Identification of Potential Novel Prognosis-Related Genes Through Transcriptome Sequencing, Bioinformatics Analysis, and Clinical Validation in Acute Myeloid Leukemia

M. Uddin, Yun Wu, Y. Xiang, 2021, Frontiers in Genetics.

Bioinformatics analysis deciphering the transcriptomic signatures associated with signalling pathways and prognosis in the myelodysplastic syndromes

Jie Wang, Rong Chen, Niluopaer Tuerxun, 2022, Hematology.

Identification of Potential Key Genes and Regulatory Markers in Essential Thrombocythemia Through Integrated Bioinformatics Analysis and Clinical Validation

M. Uddin, Yun Wu, Jie Wang, 2021, Pharmacogenomics and personalized medicine.

PGPM_A_309166 767..784

M. Uddin, Yun Wu, Jie Wang, 2021 .

Differences in Variants in the Structural Domain of BCR-ABL1 Kinase between Chinese Han and Minority Patients with Chronic Myeloid Leukemia by Sanger Sequencing and Next-Generation Sequencing

Niluopaer Tuerxun, Fang Zhao, Huan Wang, 2022, Cytogenetic and Genome Research.

[Analysis of Therapy and Efficacy after Remission of Acute Myeloid Leukemia].

Rong Chen, Jian-Ping Hao, Shuang Zhao, 2016, Zhongguo shi yan xue ye xue za zhi.

Identification of MiR-93-5p Targeted Pathogenic Markers in Acute Myeloid Leukemia through Integrative Bioinformatics Analysis and Clinical Validation

Xuan-Sheng Ding, M. Uddin, Yun Wu, 2021, Journal of oncology.

A global study for acute myeloid leukemia with RARG rearrangement

J. Welch, H. Kantarjian, Jiong Hu, 2023, Blood advances.